The Role of Pharmacy in Challenging Current Treatment Protocols. How can pharmacists across the healthcare systems drive improved patient management and care in pancreatic cancer?

The Role of Pharmacy in Challenging Current Treatment Protocols: How can pharmcists across the healthcare systems drive improved patient management and care in pancreatic cancer?

Join us on Wednesday18th May from 12.30pm - 2pm and listen to our expert speakers.

Mr Keith Roberts - Consultant Hepatobiliary and Pancreas Surgeon, Queen Elizabeth Hospital, Birmingham will discuss Pancreatic Cancer and Pancreatic Exocrine Insufficiency and The RICOCHET Data. This session will:

• Discuss the goals and objectives for the management of patients with pancreatic cancer
• Discuss the burden of pancreatic exocrine insufficiency (PEI) and the management with pancreatic enzyme replacement therapy (PERT)
• Explore current pathways and discharge methods in relation to patients with pancreatic cancer
• Review the impact of managing PEI with PERT

Andrew Walker - Senior Specialist Clinical Pharmacist – Haematology / Oncology, The Mid Yorkshire Hospitals NHS Trust will discuss Optimising Patient Care - How Pharmacy Can Help. This session will discuss:

• How pharmacists can work with the MDT to ensure that appropriate patients are prescribed PERT
• Which stakeholders you need to engage with
• What can be done to ensure patients are not missed?

This educational webinar is initiated, funded and reviewed by Viatris, organised by PM and is intended for UK Healthcare Professionals only.

CRE-2022-0193  |  March 2022